Company Profiles

driven by the PitchBook Platform

Axonics Modulation Technologies

Description

Developer of implantable neuromodulation technology. The company develops medical devices for the treatment of chronic pain and overactive bladder, among other clinical indications.

2014

Founded

PRIVATE

Status

51-200

Employees

Series B

Latest Deal Type

$38.5M

Latest Deal Amount

$59.1M

Total Amount Raised

Description

Developer of implantable neuromodulation technology. The company develops medical devices for the treatment of chronic pain and overactive bladder, among other clinical indications.

Website:

www.axonicsmodulation.com

Formerly Known As

American Restorative Medicine

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Other Industries

Surgical Devices

Primary Office

7575 Irvine Center Drive Suite 200 Irvine, CA 92618United States +1 (949) 396-6322
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Axonics Modulation Technologies's full profile, request a free trial.

Axonics Modulation Technologies Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Axonics Modulation Technologies Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Axonics Modulation Technologies Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Advent Life SciencesVenture CapitalMinority000 0000000 0000
Alfred Mann FoundationNot-For-Profit Venture CapitalMinority000 0000000 0000
Cormorant Asset ManagementHedge FundMinority000 0000000 0000
Edmond de Rothschild Investment PartnersPE/BuyoutMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
Advent Life Sciences Venture Capital
Alfred Mann Foundation Not-For-Profit Venture Capital
Cormorant Asset Management Hedge Fund
Edmond de Rothschild Investment Partners PE/Buyout
Individual Investor Angel (individual)

Axonics Modulation Technologies Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Dan DearenChief Operating & Financial Officer & Co-Founder
Guangqiang Jiang Ph.DChief Technology Officer
Prabodh MathurChief Product Development Officer
Michael Williamson JDSenior Vice President, General, IP & Patent Counsel
Courtney Lane Ph.DVice President, Clinical Affairs
Dan Dearen Chief Operating & Financial Officer & Co-Founder
Guangqiang Jiang Ph.D Chief Technology Officer
Prabodh Mathur Chief Product Development Officer
Michael Williamson JD Senior Vice President, General, IP & Patent Counsel
Courtney Lane Ph.D Vice President, Clinical Affairs

Axonics Modulation Technologies Board Members (7)

NameRepresentingRoleSinceContact
Info
Barry KeenanAxonics Modulation TechnologiesDirector000 0000
Daqing Cai Ph.DLegend CapitalManaging Director000 0000
Erik Amble Ph.DNeoMed ManagementFounder, Managing Partner & Chairman000 0000
John Petrovich JDSelfDirector000 0000
Raphaël WisniewskiEdmond de Rothschild Investment PartnersPartner & Associate Director000 0000
Barry Keenan Director Axonics Modulation Technologies
Daqing Cai Ph.D Managing Director Legend Capital
Erik Amble Ph.D Founder, Managing Partner & Chairman NeoMed Management
John Petrovich JD Director Self
Raphaël Wisniewski Partner & Associate Director Edmond de Rothschild Investment Partners
Request full access to PitchBook